Summit Securities Group’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Summit Securities Group's RXST Position: Q1 2026 in Review
Summit Securities Group opened a new position in RxSight (RXST) in Q1 2026: 4,851 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in RXST as recently as Q1 2025.
Summit Securities Group first reported a position in RXST in Q1 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Summit Securities Group held 4,851 shares of RxSight worth $29.9K as of Q1 2026.
- RxSight was a new Summit Securities Group position in Q1 2026.
- RxSight made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #459 holding.
- Summit Securities Group first reported a position in RxSight in Q1 2025 and has held it in 2 quarters since.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.